FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Handheld 3D Printing ‘Biopen’ Repairs Damaged Cartilage in Sheep

News

Researchers have shown that a handheld 3D printing pen can successfully print living cells in surgery to repair cartilage defects in sheep.

READ MORE

Liver Fluke Granulin Structural Fold Provides Wound Healing Opportunity

News

Researchers can now mass produce wound-healing peptides isolated from the spit of the human parasitic liver fluke, a worm that causes liver cancer and kills 26,000 people in Thailand each year.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE